Form 4 for FSLR First Solar
Accepted 2026-03-17 00:00:00 ET · period of report 2026-03-13 · accession 0001274494-26-000073 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-17 | 2026-03-16+ | FSLR | Bradley Alexander R. | CFO | S - Sale+OE | $200.00 | -14.7K | 44.1K | -25% | -$2.94M |
| D | 2026-03-17 | 2026-03-13 | FSLR | Bradley Alexander R. | CFO | M - OptEx | $0.00 | +1,441 | 44.7K | +3% | $0 |
| D | 2026-03-17 | 2026-03-13 | FSLR | Bradley Alexander R. | CFO | M - OptEx | $0.00 | -1,441 | 1,440 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-17 | S | D | 5,376 | $199.75 | 35,772 | D | — | — | (F3) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person on November 6, 2025. (F5) This transaction was executed in multiple trades at prices ranging from $199.23 to $200.22 The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2026-03-17 | S | D | 5,075 | $200.59 | 30,697 | D | — | — | (F3) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person on November 6, 2025. (F6) This transaction was executed in multiple trades at prices ranging from $200.23 to $201.17. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2026-03-17 | S | D | 346 | $201.65 | 30,351 | D | — | — | (F3) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person on November 6, 2025. (F7) This transaction was executed in multiple trades at prices ranging from $201.23 to $202.21. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2026-03-17 | S | D | 2,958 | $198.80 | 41,148 | D | — | — | (F3) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person on November 6, 2025. (F4) This transaction was executed in multiple trades at prices ranging from $198.23 to $199.22 The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2026-03-17 | S | D | 351 | $202.44 | 30,000 | D | — | — | (F3) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person on November 6, 2025. (F8) This transaction was executed in multiple trades at prices ranging from $202.32 to $202.55. The price reported above reflects the weighted average sale price for the transactions reported on this line. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 6 | Common | Common Stock | 2026-03-13 | M | A | 1,441 | $0.00 | 44,696 | D | — | — | (F1) Represents shares of common stock issued upon vesting of 20% of the restricted stock units granted on March 15, 2022. |
| 7 | Common | Common Stock | 2026-03-16 | S | D | 590 | $200.80 | 44,106 | D | — | — | (F2) Represents shares of common stock sold by the Issuer to satisfy certain tax withholding obligations with the vesting of the restricted stock units. |
| 8 | Derivative | Restricted Stock Units | 2026-03-13 | M | D | 1,441 | $0.00 | 1,440 | D | — · — to — | 1,441 Common Stock | (F9) Each restricted stock unit represents the right to receive, upon vesting, one share of the Issuer's common stock in accordance with the Issuer's 2020 Omnibus Incentive Compensation Plan. (F10) The restricted stock units were granted on March 15, 2022 as part of the Issuer's annual equity grant to executive officers. The restricted stock units granted on March 15, 2022 are scheduled to vest annually at a rate of 20% on each anniversary of the grant date, commencing on the first anniversary of the grant date. |